Publications

Need for and access to health care and medicines: are there gender inequities?

PLoS ONE
Wagner AK, Graves AJ, Fan Z, Walker S, Zhang F, Ross-Degnan D

Does access to medicines differ by gender? Evidence from 15 low and middle income countries.

Health Policy
Stephens P, Ross-Degnan D, Wagner AK

Changes in use of antidiabetic medications following price regulations in China (1999–2009)

J Pharm Health Serv Res
Lu CY, Ross-Degnan D, Stephens P, Liu B, Wagner AK

Improving access to medicines in low and middle income countries: corporate responsibilities in context.

South Med Rev
Leisinger KM, Garabedian LF, Wagner AK

Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study.

BMJ Open
Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK

Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico.

BMC Med Inform Decis Mak
Pérez-Cuevas R, Doubova SV, Suarez-Ortega M, Law M, Pande AH, Escobedo J, Espinosa-Larrañaga F, Ross-Degnan D, Wagner AK

Simulation-based power calculation for designing interrupted time series analyses of health policy interventions.

J Clin Epidemiol
Zhang F, Wagner AK, Ross-Degnan D

Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.

Breast Cancer Res. Treat.
Nekhlyudov L, Li L, Ross-Degnan D, Wagner AK

Household expenditures for medicines and the role of free medicines in the Brazilian public health system.

Am J Public Health
Bertoldi AD, Barros AJ, Camargo AL, Hallal PC, Vandoros S, Wagner A, Ross-Degnan D

Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey.

Health Policy
Wagner AK, Graves AJ, Reiss SK, Lecates R, Zhang F, Ross-Degnan D

Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence.

Health Policy
Faden L, Vialle-Valentin C, Ross-Degnan D, Wagner A

Health insurance systems in five Sub-Saharan African countries: medicine benefits and data for decision making.

Health Policy
Carapinha JL, Ross-Degnan D, Desta AT, Wagner AK

Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces.

BMC Health Serv Res
Chen W, Tang S, Sun J, Ross-Degnan D, Wagner AK

Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.

Med Care
Briesacher BA, Ross-Degnan D, Wagner AK, Fouayzi H, Zhang F, Gurwitz JH, Soumerai SB

Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators.

BMC Health Serv Res
Ross-Degnan D, Pierre-Jacques M, Zhang F, Tadeg H, Gitau L, Ntaganira J, Balikuddembe R, Chalker J, Wagner AK,

Urgent need for coordination in adopting standardized antiretroviral adherence performance indicators.

J. Acquir. Immune Defic. Syndr.
Chalker J, Wagner A, Tomson G, Laing R, Johnson K, Wahlström R, Ross-Degnan D,

A new measure of medication affordability.

Soc Work Public Health
Briesacher B, Ross-Degnan D, Adams A, Wagner A, Gurwitz J, Soumerai S

Medicine access and utilization in a population covered by primary health care in Brazil.

Health Policy
Bertoldi AD, de Barros AJ, Wagner A, Ross-Degnan D, Hallal PC

Methods for estimating confidence intervals in interrupted time series analyses of health interventions

J Clin Epidemiol
Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D

A descriptive review of the methodologies used in household surveys on medicine utilization.

BMC Health Serv Res
Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC